Double-digit growth seen on corporate scoreboard in Q2, but bank, IT, pharma lag
September quarter earnings exhibited significant revenue and profit growth for various companies in key sectors. Revenue rose by 22.1% with net profit increasing by 27.5%, surpassing the previous quarter. However, banking, IT, and pharmaceuticals sectors experienced a slow down in growth rates. Excluding lending, operating margins improved, indicating stronger performance in non-banking sectors. Analysts expect 13...
Key Takeaways
- September quarter earnings exhibited significant revenue and profit growth for various companies in key sectors.
- Revenue rose by 22.1% with net profit increasing by 27.5%, surpassing the previous quarter.
- However, banking, IT, and pharmaceuticals sectors experienced a slow down in growth rates.
September quarter earnings exhibited significant revenue and profit growth for various companies in key sectors. Revenue rose by 22.1% with net profit increasing by 27.5%, surpassing the previous quarter. However, banking, IT, and pharmaceuticals sectors experienced a slow down in growth rates. Excluding lending, operating margins improved, indicating stronger performance in non-banking sectors. Analysts expect 13 out of 18 sectors to deliver double-digit sales growth in the coming quarters.
Original Publisher Attribution
This summary was curated from Economic Times.